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Summary
 Background: An increasing body of evidence supports the concept that intracranial pressure (ICP) slow B waves 
represent the auto-regulatory response of spontaneous fluctuations of cerebral perfusion pressure. 
A relationship between cerebral auto-regulation and clinical outcome in patients with traumatic 
brain injury has also been established. The objective of our prospective clinical study was to com-
pare the B slow ICP waves obtained invasively by standard ICP monitoring to those obtained non-
invasively using a new ultrasound technology.
 Material/Methods: In the participating institutions, over a period of six months, thirteen consecutive patients (8 males 
and 5 females) with severe closed head injuries (GCS <8) were included in our IRB-approved study. 
Intracranial pressure and B slow waves, as well as arterial blood pressure and waveforms, were evalu-
ated by standard invasive techniques. Additionally, a new non-invasive ultrasound device, Vittamed 
(Telematics Scientific Laboratory, Kaunas, Lithuania), was employed for monitoring intracranial 
blood volume slow waves. Using these modalities, it was possible to compare the changes that oc-
curred with invasive monitoring (Correlation factor RI) and the changes that occurred using non-
invasive technology (Correlation factor RN).
 Results: Bland Altman plot analysis showed positive correlation between the invasively and non-invasively ob-
tained slow intracranial B waves (2s=8.9%, p<0.0001) and cerebral auto-regulation indexes (RI and 
RN) (SD=5%, p<0.0001). Positive RI and RN values were correlated with poor clinical outcome.
 Conclusions: Ultrasonographic technology (Vittamed) may have significant application in non-invasive contin-
uous cerebrovascular auto-regulation monitoring in patients with severe head injuries.
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Background
It is widely accepted that the slow B waves of intracranial 
pressure (ICP), as originally described by Lundberg, rep-
resent the consequence of slow variations of intracranial 
blood volume [1]. These waves are characterized as repeata-
tive alterations in the ICP at frequencies of 0.5 to 2 waves 
per minute [1]. Their duration ranges between 30 and 200 
seconds [1]. The quantitative estimation of cerebral auto-
regulation (CA) status is usually performed by calculating 
the correlation coefficient r(ICP; ABP) between the slow B 
waves of arterial blood pressure (ABP) and ICP [2].
Several recent clinical experimental studies have revealed that 
CA is a key factor in determining outcome in patients with 
traumatic brain injury [3,4]. This relationship between CA 
and outcome was found to be more significant than those pre-
viously established between outcome and physiological param-
eters, such as Glasgow Coma Scale (GCS) Score, mean arteri-
al blood pressure (ABP), mean intracranial pressure (ICP), 
and mean cerebral perfusion pressure (CPP) [3–6].
Various innovative methodologies for non-invasive monitor-
ing of ICP, CPP and CA in humans can be found in the lit-
erature [7–16]. Most of the proposed non-invasive technol-
ogies are based on ultrasound application, and have been 
used to monitor the physiological properties of various bi-
ophysical parameters, such as blood flow velocity of intrac-
ranial or intraocular vessels or pulsations of the cerebrospi-
nal fluid in the ventricular system [9–11,14,16].
The main priniciple of non-invasive CA monitoring is 
based on the measurement of ultrasound propagation 
speed through the brain parenchyma [9,17,18]. Clinical 
investigation has revealed the similarity between invasively 
recorded ICP B slow waves and the same slow waves of ABP 
characterizing the cerebral vascular resistance, which deter-
mines intracranial cerebral blood flow and is responsible for 
CA [19]. The applicability of the non-invasive intracranial 
blood volume (IBV) slow wave monitoring technique for 
CA evaluation has been established by experimental stud-
ies on animal models [4,17,18].
Non-invasive intracranial blood volume and pressure meas-
urement methodologies have been based on the assumption 
that idealized relationships exist between ultrasound propa-
gation speed in the cerebral parenchymal acoustic pathway 
and cerebral blood volume (CBV), cerebrovascular resist-
ance (CVR), CPP, ABP and ICP [9–11,14,16]. These rela-
tionships can be explained by the changes in the diameter 
of cerebral arterioles, which represent the consequence of 
cerebrovascular auto-regulation.
When auto-regulation is intact, the diameter of cerebral ar-
terioles decreases with any increase of CPP within the linear 
range of CVR/CPP dependence. The cerebral blood volume 
also changes as a result of any change in the cerebral arteri-
ole diameter. The results of a mathematical simulation show 
that the relationship between the ultrasound propagation 
speed and the cerebral blood volume is linear [4].
The concept of non-invasive monitoring of cerebral blood 
volume/ICP-CPP slow waves and trends using ultrasound 
can be summarized as follows: 
a)  the idea of measuring changes of intracranial blood vol-
ume non-invasively is based on the principle of transmit-
ting a broadband ultrasonic signal through the scalp, me-
ninges and brain parenchyma, while monitoring signal 
parameters, such as the time-of-flight [17,18]. Since the 
intracranial components (brain parenchyma, cerebro-
spinal fluid, blood) have different acoustic properties 
(ultrasound speed, frequency-dependent attenuation), 
changes of their content in the acoustic pathway direct-
ly influence the total acoustic characteristics of intracra-
nial media and the monitored parameters of the ultra-
sonic signal. Our model is based on the hypothesis that 
the ultrasonic signal propagates through the 15 cm of 
human scalp in a straight line, and that the thickness of 
cranial components is as follows: 13.270 cm of brain pa-
renchyma, 0.865 cm of CSF and 0.865 cm of blood. For 
evaluating the influence of the over-lying skin, skull and 
meninges, the thickness of extra-cranial and cranial lay-
ers on each side of the head was assumed to be equal 
to 0.8 cm;
b)  the intraventricular or supraventricular parenchymal 
acoustic pathway crossing the human scalp is used in 
this case. The acoustic pathway consists of parenchymal 
tissue, relatively small blood vessels (arterioles, venules 
and capillaries), and a small amount of cerebrospinal 
fluid. The parenchymal arterioles determine the cere-
brovascular auto-regulation. Blood volume in this path-
way is the main factor determining ultrasound propaga-
tion speed. The ultrasound attenuation in this pathway 
depends mainly on the volume of parenchymal tissue;
c)  it is known that dynamic CA can be reflected by the ex-
istence of latency of the cerebro-vascular auto-regulatory 
system [2]. Different latency is observed over a frequency 
range, higher for slow B waves and lower for spontane-
ous waves over the range of 0.1 Hz to 0.5 Hz. A conven-
ient way to evaluate the latency of the auto-regulatory sys-
tem is to measure the phase shift between the slow ABP 
and the slow ICP B waves and to calculate the correla-
tion coefficient r(ICP, ABP) between them. In the case 
of intact CA, the phase of the slow ICP wave is nearly op-
posite to the phase of the slow ABP wave of the same fre-
quency, and the value r(ICP, ABP) is close to –1.0 [2]. 
Thus any increase in the CPP (within physiological lim-
its) is accompanied by an active constriction of the cere-
bral arterioles. In the case of impaired CA, however, any 
increase of ABP is accompanied by passive dilatation of 
cerebral arterioles. This results in the absence of phase 
shift between the slow ICP and ABP waves and gives pos-
itive values of r(ICP; ABP) up to +1.0 [2].
The implementation of the CA monitoring method requires 
a co-existent invasive monitoring of ICP and ABP slow waves. 
For the non-invasive implementation of the method, the data 
of the invasive ICP slow waves could be replaced by non-
invasively measured slow waves of the relative ultrasound 
propagation speed attenuation DC/C0 in brain parenchy-
ma, a fact that also reflects slow variations of the intracra-
nial blood volume. Consequently, the estimation of CA can 
be performed by calculating the correlation coefficient be-
tween ABP and DC/C0 slow B waves. The same ABP slow B 
waves are used to calculate both the invasive estimate r(ICP; 
ABP) and the non-invasive estimate r(DC/C0; ABP). In this 
case, r(ICP,ABP) is close to r(DC/C0; ABP) when the cor-
relation coefficient r(DC/C0; ICP), between non-invasively 
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recorded parenchymal blood volume slow waves and inva-
sively recorded ICP slow waves is close to +1.0.
Volume changes of intracranial components were set at ±8 
ml because such levels of increase of the intracranial volume 
can cause an increase of ICP up to the critical level of 25 
mmHg. This volume change (±8ml) is also typical for slow B 
waves, the appearance of which might be indicative of possi-
ble impairment of cerebrovascular auto-regulation.
The objective of this prospective clinical study was to com-
pare non-invasively obtained data on intracranial pressure 
slow B waveform analysis and cerebral auto-regulation in-
dexes with the data obtained invasively by employing stand-
ard ICP monitoring.
Material and Methods
A new, non-invasive brain physiological monitoring tech-
nology (Vittamed) has been developed in the Telematics 
Scientific Laboratory of the Kaunas University of Technology 
(Kaunas, Lithuania) (Figure 1). This new technology is based 
on the non-invasive measurement of acoustic properties 
of the intracranial media reflected by ultrasound propa-
gation speed and attenuation in the parenchymal acous-
tic pathway.
The previously described non-invasive ultra-sonic monitor-
ing device (Vittamed) was employed in a neuro-intensive 
care unit setting in the participating institutions, for non-
invasive slow-wave ABP monitoring. A standard invasive ICP 
monitor (INTEGRA NeuroSciences, NJ, USA) and the inva-
sive ABP monitor (Datex, Helsinki, Finland) were also em-
ployed for all of our patients. Simultaneous monitoring of 
ICP, ABP and DC/C0 was performed, and the recorded data 
were used for the estimation of slow waves, slow trends, and 
selected indices [r(DC/C0;ABP), r(ICP;ABP), and r(DC/C0; 
ICP)] of the CA status (Figure 2).
Thirteen patients (8 males and 5 females) with severe trau-
matic brain injury (GCS<8) were simultaneously monitored 
invasively and non-invasively. The patients’ mean age was 
ranged between 18 and 64 years, with a mean age of 31.2±0.5 
years. Fifty-six one-hour sessions of invasive and non-inva-
sive CA monitoring and 87 one-hour sessions of ICP and 
DC/C0 simultaneous monitoring were performed during 
this clinical trial.
results
The time span when the correlation coefficient r(DC/C0; 
ICP) exceeded 0.9 was 40% of the total monitoring time 
(34.8/87hrs). The value of the correlation coefficient 
r(DC/C0; ICP) was above 0.6 during 80% (69.6/87 hrs) of 
the total monitoring time.
Invasive and non-invasive monitoring of slow waves was com-
parable in 80 of the total 87 hrs of monitoring time (91.9%), 
while CA showed agreement between invasive and non-in-
vasive results – r(DC/C0; ABP) ~ r(ICP; ABP) – in 78/87 hrs 
(89.6%) of monitoring time. The mean amplitude of CPP 
slow waves was above 3 mmHg during all these monitoring 
sessions. The correlation coefficient r(DC/C0; ICP) was close 
to +1.0 when the state of CA was changing between intact 
(r<0) and impaired (r>0) (Figure 3A,B). The Bland Altman 
plot of invasively and non-invasively measured slow waves 
and the distribution of differences between these waves re-
vealed strong correlation between invasively and non-inva-
sively measured diagnostic data, with clinically insignificant 
negligible dispersion.
Statistical analysis
Statistical analysis was employed to assess the similarity be-
tween the invasively monitored ICP B slow-waves and the 
non-invasively monitored DC/C0 slow waves. Two types of 
Figure 1. Schematic diagram of the Vittamed device.
Figure 2.  Simultaneous monitoring of cerebral auto-regulation 
estimating indices for 1-hour monitoring session.
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data sets were evaluated for each session of monitoring. 
The first type of data sets, which included all measurement 
points, were checked by calculating the standard deviation 
and the mean of differences between the normalized inva-
sive and non-invasive data and the correlation coefficient 
between these data. The second type of data sets, includ-
ing randomly selected data points, were statistically evalu-
ated by performing a paired t-test. The values of t-criteri-
on corresponding to each data set were calculated using 
normalized data. Normalization was performed by divid-
ing the original measurement data by standard deviation. 




• t is the calculated value of t-criterion of paired samples;
• Tcrit is the critical value of t-statistics;
• a is the significance level of the test;
• n is the number of randomly selected points.
The investigated number of samples was N=87. The ob-
tained proportion of samples with positive results in terms 
of the t-criterion was higher than the proportion of interest 
(p=0.95), which confirms the hypothesis for the coincidence 
of invasively and non-invasively measured slow waves:
pN+=N+/N=0.954. (2)
It was also determined that the coefficient r(DC/C0; ICP) 
exceeded 0.9 when the amplitude of the CPP B waves was 
above 3 mmHg. Therefore, it would be useful to implement 
CPP slow wave amplitude measurements to assess the meas-
urement reliability of non-invasive slow waves.
discussion
The extensive use of invasive ICP monitoring in modern 
neurosurgery has been well justified in the literature [20–
23]. Its importance in the management of patients, mostly 
but not exclusively those with severe head injuries, is wide-
ly accepted [20–27]. The accurate knowledge of the ICP 
and CPP is important in predicting the overall outcome of 
these patients [28,29].
The Vittamed device has been tested in large animal exper-
imental studies, as well as in a previous clinical study per-
formed in our institution [17,18]. These studies showed a 
significant correlation between invasively and non-invasive-
ly measured ICP [17,18].
The complications related to the application of invasive ICP 
monitoring devices, though rare, render the idea of employ-
ing non-invasive ultrasonographic technology very appealing 
[18,26,30–32]. The Vittamed device is definitely advantageous 
compared to the existent ICP monitoring methods, since no 
intervention is necessary. The patients, particularly children, 
tolerate the application of the monitoring device significant-
ly better, since no skin penetration is necessary for applying 
the Vittamed helmet and there is no discomfort associated 
with the monitoring process [18]. Invasive ICP monitoring 
has been associated with infection, which has been report-
ed in different series at a frequency up to 22%, depending 
on the nature of the monitoring device, the insertion tech-
nique, the patients’ underlying pathology, amd the dura-
tion of monitoring [33], and with intra-cranial hemorrhage 
(which has been reported in only 1–2% of the cases but with 
unfortunately devastating results) [34,35]. These risks do not 
arise in connection with the use of the Vittamed device, since 
no intervention is necessary [18,32,36]. The monitored pa-
tients do not need to be placed in the intensive care unit for 
monitoring, a fact which dramatically minimizes the cost of 
the monitoring. Additionally, the non-invasive character of 
the ultrasonic device used makes to possible to monitor ICP, 
CPP, CBV and CSF volume even in patients with clotting ab-
normalities, a clinical situation not at all infrequent in pa-
tients with traumatic brain injuries. Moreover, in patients for 
whom invasive ICP monitoring has to be discontinued either 
due to increased risk of infection, prolonged monitoring, or 
patient’s temporary improvement and a newly observed de-
terioration, the Vittamed technology gives the opportunity 
for prolonged monitoring.
Although the concept that ICP monitoring maximizes the pa-
tient’s outcome is gaining popularity, it has remained contro-
versial even so. Indeed, the exclusive monitoring of ICP miss-
es important neurophysiological events and ignores several 
other physiological parameters that have been implicated in 
the pathophysiological mechanisms occuring during and af-
ter a traumatic brain injury. It is widely accepted that impaired 
cerebral auto-regulation is only indirectly reflected in ICP al-
Figure 3.  Estimating the similarity between the normalized 
slow-waves of invasive ICP and non-invasive DC/Co. 
(A) Distribution of differences between the non-invasive 
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terations. Importantly, the Vittamed technology appears to 
have the ability to offer major insights into such neurophys-
iological changes. The Vittamed device allows the neurosur-
geon to monitor and record easily real time multi-parameter 
information, such as variation of CBF, CA, CVB and CSF. The 
accurate knowledge of the cerebral blood and cerebrospinal 
fluid volumes is valuable direct data indicating the presence 
or absence of edema and brain parenchyma compliance. This 
significant information could dramatically alter the manage-
ment of patients with intracranial hypertension.
The customary invasive methods provide information about 
the patient’s brain metabolic activity, such as regional meas-
urements of the pH, pO2, pCO2 and intra-cranial temper-
ature, which are definitely irreplaceable, particularly in 
critically ill patients. In these circumstances, however, the 
Vittamed device can reasonably act as a screening non-in-
vasive method for determining the necessity to implement 
such invasive, traditional monitoring.
Unfortunately, the invasive character of the customary ICP 
monitoring modalities and its associated complications lim-
it the use of such methods only to patients with severe intra-
cranial pathology. Our non-invasive method minimizes these 
limitations and could possibly expand the application of ICP, 
CPP, CBV and CA monitoring in the evaluation of patients 
with hydrocephalus, pseudotumor cerebri, minor head in-
juries, spinal cord injuries and chronic headaches. A multi-
institutional, prospective clinical study is currently underway 
to collect data from use of the Vittamed monitoring device in 
patients with traumatic brain injury, and another study in pa-
tients with spinal canal compromise of traumatic etiology.
conclusions
The non-invasive monitoring of ABP and cerebral blood vol-
ume slow wave, as well as CA status, using a Vittamed ultra-
sonographic device, is a safe and promising technology, which 
could in some cases replace – and in others, enhance, and 
possibly expand – the use of the existent invasive technology 
in the evaluation of several different intracranial pathological 
entities. The implementation of non-invasive human cerebrov-
ascular auto-regulation monitoring is possible by measuring 
non-invasively slow DC/C0 waves (instead of ICP) and by cal-
culating the correlation coefficient between the slow waves of 
DC/C0 and ABP. The non-invasive character of this modality 
becomes more important when the method is applied to pedi-
atric patients. Further multi-institutional prospective clinical 
studies are necessary to validate the accuracy of this advanced 
technology in estimating cerebral auto-regulation.
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